Due to health issues, this site is no longer maintained and will be shut down shortly. |
DBV Technologies SA is a biopharmaceutical company. It is engaged in research and development of patient-friendly therapy for food and pediatric allergy patients. This is an ADR of a company whose stock trades outside of the U.S. as the symbol FP:DBV.
$1.60 +0.02 (1.27%)
As of 03/27/2023 11:07:54 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.